The estimated risk up to 80 years of age for ovarian and breast cancer among women with BRCA1 and BRCA2 pathogenic germline gene variants is 44 and 72% respectively for BRCA1 and 17 and 69% respectively for BRCA2 [1]. The gene discussed is BRCA2; the disease is breast carcinoma.